Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00665782 · ClinicalTrials.gov registry record
Measuring Stress in Women With Newly Diagnosed Stage I, Stage II, or Stage III Breast Cancer or Ductal Carcinoma In Situ of the Breast
A clinical trial, sponsored by Wake Forest University Health Sciences.
- Completed
- Registry status
- 24
- Enrollment target
NCT00665782 is a clinical trial that has completed, run by Wake Forest University Health Sciences. The registered enrollment target is 24 participants.
The verdict
NCT00665782 has completed, sponsored by Wake Forest University Health Sciences.
- COMPLETED
- Registry status
- 24 participants
- Enrollment target
Study Summary
RATIONALE: Gathering information about how patients respond to stress and measuring stress levels in women with newly diagnosed breast cancer may help doctors provide better methods of treatment and on-going care. PURPOSE: This research study is measuring stress in women with newly diagnosed stage I, stage II, or stage III breast cancer or ductal carcinoma in situ of the breast.
Interventions
- OTHER laboratory biomarker analysis
- OTHER questionnaire administration
- OTHER study of socioeconomic and demographic variables
- PROCEDURE psychosocial assessment and care
- PROCEDURE assessment of therapy complications
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2008-03 |
| Est. Completion | 2010-07 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00665782
The ClinicalTrials.gov registry entry for NCT00665782 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 24 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Wake Forest University Health Sciences, which has 1,140 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which laboratory biomarker analysis is the first listed.
NCT00665782 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00665782 about?
NCT00665782 is a clinical study titled "Measuring Stress in Women With Newly Diagnosed Stage I, Stage II, or Stage III Breast Cancer or Ductal Carcinoma In Situ of the Breast". RATIONALE: Gathering information about how patients respond to stress and measuring stress levels in women with newly diagnosed breast cancer may help doctors provide better methods of treatment and on-going care. PURPOSE: This research study is measuring stress in women with newly diagnosed stage ...
What is the current status of trial NCT00665782?
This trial is currently completed. The enrollment target is 24 participants. The study started on 2008-03. Estimated completion is 2010-07.
What interventions are being tested in trial NCT00665782?
The interventions under investigation include: laboratory biomarker analysis (OTHER), questionnaire administration (OTHER), study of socioeconomic and demographic variables (OTHER), psychosocial assessment and care (PROCEDURE), assessment of therapy complications (PROCEDURE).
Who is sponsoring clinical trial NCT00665782?
This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.